混合磁共振正电子发射断层成像与心脏结节病的心脏相关结局相关
该研究纳入148例疑似心脏结节病患者行混合MR/PET成像,按LGE和18F-FDG表现分类,发现MR(+)5.7%PET(+)FOCAL分类与主要临床终点(心脏骤停、室性心动过速或二级预防ICD植入)的比值比为9.2(95%CI:3.0-28.7;P=0.0001),TNMRmax对区分该分类的AUC为0.90,对区分是否达到临床终点的AUC为0.77。
要点
- MR(+)5.7%PET(+)FOCAL分类与主要临床终点相关,未校正OR为9.2(95%CI:3.0-28.7;P=0.0001)。
- TNMRmax区分MR(+)PET(+)FOCAL的AUC为0.90,区分是否达到临床终点的AUC为0.77。
- 联合MR与PET的影像分类可能用于心脏结节病的预后判断和治疗管理。
核心结论
- 基于混合MR/PET的CS影像分类与临床结局存在统计学关联,TNMRmax对MR(+)PET(+)FOCAL分类具有中等敏感度和特异度并与结局相关,联合MR和PET的影像分类可能用于预后判断和治疗管理。
研究设计与样本
- 共148例疑似心脏结节病患者行混合MR/PET成像,根据LGE存在与否(MR+/MR-)、18F-FDG存在与否(PET+/PET-)及18F-FDG摄取模式(局灶/弥漫)分类为MR(+)PET(+)FOCAL、MR(+)PET(+)DIFFUSE、MR(+)PET(-)、MR(-)PET(+)FOCAL、MR(-)PET(+)DIFFUSE、MR(-)PET(-),并以%LGE超过5.7%定义MR(+/-)5.7%,测量标准摄取值、靶本底比、靶/正常心肌比(TNMRmax)和T2定量值。
诊断标准与关键数值
- MR(+)5.7%PET(+)FOCAL患者达到主要临床终点的未校正OR为9.2(95%CI:3.0-28.7;P=0.0001),高于单独基于MR或PET的比值比;TNMRmax区分MR(+)PET(+)FOCAL与非MR(+)PET(+)FOCAL的AUC为0.90,区分达到与未达到临床终点者的AUC为0.77。
临床应用与阅片要点
- 原文结论认为联合MR和PET的影像分类可能用于心脏结节病的预后判断和治疗管理。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Imaging with late gadolinium enhancement (LGE) magnetic resonance (MR) and 18F-fluorodeoxyglucose (18F-FDG) PET allows complementary assessment of myocardial injury and disease activity and has shown promise for improved characterization of active cardiac sarcoidosis (CS) based on the combined positive imaging outcome, MR(+)PET(+).
OBJECTIVES: This study aims to evaluate qualitative and quantitative assessments of hybrid MR/PET imaging in CS and to evaluate its association with cardiac-related outcomes.
METHODS: A total of 148 patients with suspected CS underwent hybrid MR/PET imaging. Patients were classified based on the presence/absence of LGE (MR+/MR-), presence/absence of 18F-FDG (PET+/PET-), and pattern of 18F-FDG uptake (focal/diffuse) into the following categories: MR(+)PET(+)FOCAL, MR(+)PET(+)DIFFUSE, MR(+)PET(-), MR(-)PET(+)FOCAL, MR(-)PET(+)DIFFUSE, MR(-)PET(-). Further analysis classified MR positivity based on %LGE exceeding 5.7% as MR(+/-)5.7%. Quantitative values of standard uptake value, target-to-background ratio, target-to-normal-myocardium ratio (TNMRmax), and T2 were measured. The primary clinical endpoint was met by the occurrence of cardiac arrest, ventricular tachycardia, or secondary prevention implantable cardioverter-defibrillator (ICD) before the end of the study. The secondary endpoint was met by any of the primary endpoint criteria plus heart failure or heart block. MR/PET imaging results were compared between those meeting or not meeting the clinical endpoints.
RESULTS: Patients designated MR(+)5.7%PET(+)FOCAL had increased odds of meeting the primary clinical endpoint compared to those with all other imaging classifications (unadjusted OR: 9.2 [95% CI: 3.0-28.7]; P = 0.0001), which was higher than the odds based on MR or PET alone. TNMRmax achieved an area under the receiver-operating characteristic curve of 0.90 for separating MR(+)PET(+)FOCAL from non-MR(+)PET(+)FOCAL, and 0.77 for separating those reaching the clinical endpoint from those not reaching the clinical endpoint.
CONCLUSIONS: Hybrid MR/PET image-based classification of CS was statistically associated with clinical outcomes in CS. TNMRmax had modest sensitivity and specificity for quantifying the imaging-based classification MR(+)PET(+)FOCAL and was associated with outcomes. Use of combined MR and PET image-based classification may have use in prognostication and treatment management in CS.
引用
- Trivieri MG, Robson PM, Vergani V, et al. Hybrid Magnetic Resonance Positron Emission Tomography Is Associated With Cardiac-Related Outcomes in Cardiac Sarcoidosis. JACC Cardiovasc Imaging. 2024. PMID: 38300202. doi:10.1016/j.jcmg.2023.11.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。